Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: Efficacy and safety in the phase III randomized factorial ASPECT trial.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Janusz Jankowski, John de Caestecker, Sharon Love, Gavin Reilly, Yeng Ang, Krish Ragunath, Arthur Tucker, Ian Penman, Colin Rodgers, Emma Roffe, Claire E. Brooks, Stephen Attwood, Danielle Morris, Rebecca Harrison, Pradeep Bhandari, Peter Watson, Scott Sanders, Hugh Barr, Paul Moayyedi, James Neale, AspECT Trial Team
Institutions: University of Lancashire, University Hospitals of Leicester NHS Trust, Nuffield Orthopaedic Centre, University of Oxford, Wrightington, Wigan and Leigh NHS Foundation Trust, Nottingham University Hospitals NHS Trust, Queen Mary University of London, NHS Lothian, Northern Health and Social Care Trust, Takeda (United Kingdom), Durham University, East and North Hertfordshire NHS Trust, Portsmouth Hospitals NHS Trust, Queen's University Belfast, Ninewells Hospital, McMaster University, Torbay and South Devon NHS Foundation Trust
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2806064604